In the present study, we used paired HCC and NT tissue samples to quantitatively evaluate tumor-specific changes in expression levels of VEGFA isoforms, ratios between them and correlations of these changes with clinically relevant tumor properties. The gene discussed is VEGFA; the disease is hepatocellular carcinoma.